Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Spain’s Heat Fuels Attacks on Healthcare Workers

Summer crowds, soaring temperatures, and overloaded clinics are driving more aggression against healthcare staff across Spain, especially in primary care and emergency departments.

Emergency Department Noise Levels Exceed Safety Thresholds

Emergency department noise levels consistently exceed recommended safety thresholds and coincide with more communication-related safety events, a study finds.

Algorithm Rules Out Pulmonary Embolism in Cancer Patients

A clinical trial finds that an algorithm routinely used to rule out pulmonary embolism works in patients with cancer, too — and could avoid up to 80,000 CT scans per year in the US.

AKA Underdiagnosed in Alcohol-Related ED Visits

More than 1 in 10 patients with alcohol-related emergency visits have alcoholic ketoacidosis, a study finds, highlighting that the condition is often underdiagnosed.

Public Wary of AI Scribes for Sensitive Consultations

A Healthwatch England poll finds most people want explicit consent and human oversight when AI scribes are used in NHS appointments.

Heat Exposure Tied to AD Biomarker Changes in Women

Long-term exposure to outdoor heat was associated with lower amyloid-beta42/40 and higher p-tau181 levels in older women, but not men, suggesting heat may influence early AD-related pathology.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

Summer crowds, soaring temperatures, and overloaded clinics are driving more aggression against healthcare staff across Spain, especially in primary care and emergency departments.

Emergency department noise levels consistently exceed recommended safety thresholds and coincide with more communication-related safety events, a study finds.

A clinical trial finds that an algorithm routinely used to rule out pulmonary embolism works in patients with cancer, too — and could avoid up to 80,000 CT scans per year in the US.

More than 1 in 10 patients with alcohol-related emergency visits have alcoholic ketoacidosis, a study finds, highlighting that the condition is often underdiagnosed.

A Healthwatch England poll finds most people want explicit consent and human oversight when AI scribes are used in NHS appointments.

Long-term exposure to outdoor heat was associated with lower amyloid-beta42/40 and higher p-tau181 levels in older women, but not men, suggesting heat may influence early AD-related pathology.

News All Time

Ovarian Cancer Frequently Diagnosed Only After Hospital Admission

— Post-admission diagnoses three times as likely to be advanced-stage at recognition

As Hospitals Become Insurers, Hospitalists’ Role Expands

More health systems are adopting the ‘payvider’ system to eliminate conflict between the system and insurers.

HHS Offers $281 Million in Grants for Addiction and Mental Health Programs

The U.S. Department of Health and Human Services said ⁠on Monday it is making available more than $281 million in ⁠grant funding opportunities across 15 programs aimed at...

Italy Condemns Hospital Security Over Fentanyl Theft

Italy's government said on Friday 80 vials of ⁠fentanyl had been stolen from a hospital in Rome and ⁠denounced the "irresponsible conduct" of those tasked with ensuring the...

European Regulators Warn About Glycerin in Slushies

EFSA has raised concerns that glycerin-heavy slushies can cause nausea, vomiting, and drowsiness after one serving.

Rates of Youth Mental Health Visits Higher in Deprived Areas

Youth living in lower-opportunity areas have significantly higher rates of mental health ED visits than those living in higher-opportunity areas, independent of demographic and geographic factors.

Elevated Transaminases May Predict Flu Severity in Children

High transaminase levels are linked to the risk for severe complications, including ICU admission and death, in children hospitalised with influenza infection and can be used as a severity marker.

From Vulnerable to Vaccinated: Applying the Latest Recommendations and Evidence to Support Childhood Immunization

From Vulnerable to Vaccinated: Applying the Latest Recommendations and Evidence to Support Childhood Immunization

From Vulnerable to Vaccinated: Applying the Latest Recommendations and Evidence to Support Childhood Immunization

From Vulnerable to Vaccinated: Applying the Latest Recommendations and Evidence to Support Childhood Immunization

RFK Jr. Aide Quits in Protest; ICE Releases Doctor; Osteoporosis Tied to Mortality

Health news and commentary gathered by MedPage Today staff

What Your Patient Couldn’t Tell the Dispatcher

Health literacy matters at every stage of care

The World Cup Is Coming. Here’s What EDs Should Prepare For.

Heat, cardiac events, behavioral health, security threats, and infectious disease are all at play

What Caused Boy in Rural Area to Develop High Fever and Hemoptysis?

Rural life has its hazards, as clinicians in China explain

The Case Against Calling It 'Emergency Medicine'

The misnomer legitimizes overutilization and may be causing harm

ACEP President: Emergency Medicine Is Here to Stay

Claims that EDs are too costly and overused miss the mark

Hospitals Are Using AI to Detect Intimate Partner Violence. That's a Problem.

Survivors should decide when they share and with whom

Recommended News For You

When a Groundbreaking Cancer Therapy Causes Cancer.

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

Use of social media during pregnancy may increase depression.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

Study reveals increase in late-stage breast cancer diagnoses in US

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

After two years, a significant left nasal obstruction was finally diagnosed.

Recommended Articles For You

Survivorship Planning Beyond Active Cancer Care 

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key 

Prevention of Thrombotic Complications in High-Risk Patients 

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".

2.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

3.

FDA approves Blenrep for relapsed or refractory multiple myeloma

4.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

5.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

1.

The importance of understanding normal serum osmolality

2.

Innovative Approaches in Oncology for Modern Medicine

3.

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management

4.

The Future of Hematology: Innovations Every Doctor Should Know

5.

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part III

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

5.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot